期刊文献+

高尿酸血症与冠心病及危险因素的相关性分析 被引量:40

Relationship between Hyperuricemia,Coronary Heart Disease and Its Risk Factors
下载PDF
导出
摘要 目的通过对高尿酸血症与冠心病及危险因素的横断面研究,分析高尿酸血症与冠心病及危险因素的相关性。方法入选太原市中心医院心内科符合标准患者150例,依据尿酸水平分为高尿酸血症组(80例)及非高尿酸血症组(70例)。记录年龄、性别、身高、体重、腰围、臀围、血压及血生化指标等基本资料,通过横断面研究高尿酸血症与冠心病及危险因素的关系。结果高尿酸血症组与非高尿酸血症组比较,在吸烟年限、收缩压(SBP)、舒张压(DBP)、腰围、腰臀比、体重指数(BMI)、三酰甘油、总胆固醇、空腹血糖等均有统计学意义(P<0.05)。高尿酸与冠心病间存在相关性。针对高尿酸血症危险因素空腹血糖(FBG)、低密度脂蛋白胆固醇(LDL-C)、BMI以及代谢综合征(MS)四者进行多元Logistic回归分析,并校正年龄、性别、吸烟、饮酒后分析表明,MS(校正前OR=1.110,校正后OR=1.111,P<0.001)及FBG(校正前OR=2.586,校正后OR=2.685,P<0.001)是高尿酸血症的独立危险因素,而LDL-C(校正前OR=0.638,校正后OR=0.642,P<0.05)则是高尿酸血症的保护因素。BMI的Logistic回归分析无统计学意义(校正前OR=0.795,校正后OR=0.757)。结论高尿酸血症与冠心病存在一定的协同作用;在高尿酸血症的危险因素中MS、FBG是高尿酸血症的独立危险因素,LDL-C是高尿酸血症的保护因素。 Objective To analyze the relationship between hyperuricemia,coronary heart disease and its risk factors.Methods One hundreds and fifty patients(pts) were divided into high uric acid group(n=80) and non-high uric acid group(n=70).The age,sex,height,weight,waist circumference(WC),hip circumference(BP),blood pressure,blood glucose,creatinine,uric acid,total cholesterol(TC),triglyceride(TG),low density lipoprotein-cholesterol(LDL-C) and high density lipoprotein-cholesterol(HDL-C) and other basic information were recorded and analyzed by cross-sectional study.Results There were significantly difference in years of smoking,systolic BP(SBP),diastolic BP(DBP),WC,waist to hip(WHR),body mass index(BMI),TG,TC,fasting blood glucose(FBG),and creatinine in two groups(P0.05).Adjusting for age,sex,smoking,and alcohol consumption,FBG,LDL-C,BMI and metabolic syndrome(MS) were analyzed by multivariate logistic regression analysis and showed MS[odds ratio(OR)=1.110,adjusted OR=1.111,P0.001],FBG(OR=2.586,adjusted OR=2.685,P0.001),and higher serum uric acid were independent risk factor.LDL-C(OR=0.638,adjusted OR=0.642,P0.05) was a protective factor for hyperuricemia.There was no relation between hyperuricemia and BMI(OR=0.795,adjusted OR=0.757).Conclusion There is certain relation between coronary heart disease and hyperuricemia.MS and FBG is an independent risk factor of hyperuricemia,and LDL-C is a protective factor of hyperuricemia.
出处 《中西医结合心脑血管病杂志》 2012年第1期9-11,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 高尿酸血症 冠心病 危险因素 代谢综合征 hyperuricemia coronary heart disease risk factor metabolic syndrome
  • 相关文献

参考文献20

  • 1Chu NF, Wang DJ, Lion SH, et al. Relationship between hyperurieemia and other cardiovascular disease risk factors among adult males in Taiwan[J]. Eur J Epidemiol,2000,16(1) : 13.
  • 2Bo Isomaa MD,Peter Almgren MSC,Tiinamaija Tuomi MD,et al. Cardiovascular morbiclity and mortality associated with the metabolic syndrome[J]. Diabetes Care April, 2001,24 (4) : 683-689.
  • 3Ampion J, Maestro B, Molero S,et al. Aldosterone impairs insulin responsiveness in U-937 human promonocytic cells via the down regulation of its own receptor[J]. G Biochem Funct, 2002,20 : 237-245.
  • 4李瑞杰,富丽娟.高尿酸血症与代谢综合征[J].中国临床医生杂志,2009,37(1):16-18. 被引量:18
  • 5Sakai H, Shichiri M, Hirata Y,et al. Hypouricemia in diabetes mellitus[J]. Nippon Rinsho, 2003,61 : 390-392.
  • 6王吉耀.内科学[M].北京:人民卫生出版社,2003.884.
  • 7叶任高.内科学[M].北京:人民卫生出版社,2002.32.
  • 8中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(1):5-10. 被引量:3332
  • 9中国高血压防治指南修订委员会.中国高血压防治指南2005年修订版[M].北京:人民卫生出版社,2005:17.
  • 10IDF Clinical Guidelines Task Force (2006) Global Guideline for Type 2 Diabetes : Recommendations for standard, comprehensive, and minimal care[J]. Diabetic Medicine,2006,23(6) :579593.

二级参考文献33

  • 1张红叶,杨军,周北凡,武阳丰,李莹,陶寿淇.我国十组人群脑卒中危险因素的前瞻性研究[J].中国慢性病预防与控制,1996,4(4):150-152. 被引量:91
  • 2Fang J.血尿酸与心血管病死亡率:1971-1992年NHANES1流行病学随访研究[J].国外医学:心血管疾病分册,2000,27(6):363-363.
  • 3曹家琪 连志浩 等.队列(群组)研究.流行病学,第2版,第1卷[M].北京:人民卫生出版社,1995.190-206.
  • 4Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 5Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 6Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 7Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 8Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 9Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 10Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.

共引文献4888

同被引文献389

引证文献40

二级引证文献271

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部